Pfizer, Moderna vaccines effective against COVID-19 variants found in India: Study
3 years, 9 months ago

Pfizer, Moderna vaccines effective against COVID-19 variants found in India: Study

India TV News  

The Pfizer/BioNTech and Moderna coronavirus vaccines appear to protect against COVID variants B.1.617 and B.1.618 first identified in India, researchers have reported in a new pre-print paper, which has not yet been peer-reviewed, CNN reported. "Thus, there is a good reason to believe that vaccinated individuals will remain protected against the B.1.617 and B.1.618 variants," the researchers from New York University wrote in their paper. Moreover, the World Health Organization has classified the coronavirus variant first found in India as a "variant of global concern".It said studies show the B.1.617 mutation spreads more easily than other variants and requires further study, CNN reported. The researchers also examined how Regeneron's monoclonal antibody cocktail therapy, called REGN-COV2, worked against the lentiviruses with B.1.617 and B.1.618 mutations -- and both appeared to be "partially resistant" to the therapy.

Vaccines Variants Covid Moderna Pfizer Moderna Vaccines India Researchers  vaccines  covid19  india  researchers  pfizerbiontech  vaccinated  resistant  effective  pfizer  study  b1618  b1617  moderna  serum  variants

History of this topic

FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines
9 months, 1 week ago

FDA advisers urge targeting JN.1 strain in recipe for fall's COVID vaccines

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Government advisers Wednesday said it’s …

With State prod, India can be world leader in vaccines
1 year, 1 month ago

With State prod, India can be world leader in vaccines

Hindustan Times  

The World Health Organization activated its incident management support team as part of its emergency response framework on the emergence of a cluster of atypical pneumonia cases emerging from Wuhan, China, on January 1, 2020. India, the dark horse in the vaccine race, did the unexpected and against all odds, approving EUA to two vaccines — “made in India” Covishield …

New COVID variant JN.1: Health Ministry says no need for booster dose
1 year, 2 months ago

New COVID variant JN.1: Health Ministry says no need for booster dose

The Hindu  

Following the Union Health Ministry direction that States be alert and prepared for any possible surge in COVID-19 cases following the emergence of the new variant JN.1, senior health officials said that there is no move to recommend administration of vaccine booster dose for India. India saw a single-day rise of 656 COVID-1 infections while the active cases have increased …

Covid in India Highlights: Maharashtra reports nine JN.1 infections
1 year, 2 months ago

Covid in India Highlights: Maharashtra reports nine JN.1 infections

Hindustan Times  

Covid in India Highlights: India logged a total of 656 fresh cases of Covid-19 infections on December 24. Former AIIMS, Delhi, director Randeep Guleria said the sub-variant JN.1 is “gradually becoming dominant” but observed that it is not causing severe infections or hospitalisations. The World Health Organisation also classified JN.1 into the Variant of Interest category, however, said there is …

New variant won’t affect most people: BHU don
1 year, 2 months ago

New variant won’t affect most people: BHU don

Hindustan Times  

Prof Gyaneshwar Chaubey, department of Zoology, BHU, said that JN.1, the new variant of Covid-19, will hardly have any adverse effect on much of the population in India as more than 90% of India’s population has been infected by Covid-19 at one point or another. For representation only Prof Chaubey, however, said that elderly people and those who have comorbidities …

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise
1 year, 3 months ago

New COVID-19 vaccines available in Australia: Millions urged to get a booster as cases rise

Daily Mail  

New COVID-19 vaccines targeting the current Omicron variant of the virus are available in community pharmacies throughout Australia. Pharmacy Guild of Australia National President Trent Twomey says the new vaccine available on Monday is targeted at the strain of the virus which is currently circulating among the population. 'With COVID-19 cases on the rise, it is important anyone who is …

The Vaccine War: A tale of Indian scientists' triumph over COVID-19 amid the Left's propaganda to undermine indigenous vaccine
1 year, 5 months ago

The Vaccine War: A tale of Indian scientists' triumph over COVID-19 amid the Left's propaganda to undermine indigenous vaccine

Op India  

Recalling the dreadful chapters from the year 2020 when the spread of novel coronavirus in India killed several lives, affected many businesses, and derailed the normal routine lives of almost all is difficult. But Vivek Ranjan Agnihotri, the marvellous director who earlier amazed audiences with movies like ‘The Kashmir Files’ and ‘The Tashkent Files’ has made an attempt to bring …

US FDA authorizes Pfizer-BioNTech, Moderna's updated Covid shots
1 year, 6 months ago

US FDA authorizes Pfizer-BioNTech, Moderna's updated Covid shots

India Today  

The U.S. Food and Drug Administration on Monday authorized updated Covid-19 vaccines from Pfizer/BioNTech and Moderna that target a recently circulating Omicron variant of the coronavirus, paving the way for the launch later this week of a fall vaccination campaign. Pfizer and Moderna said their updated vaccines, which target the XBB.1.5 subvariant of the virus, were expected to be available …

Moderna says updated COVID vaccine is effective against ‘highly-mutated’ BA.2.86 variant
1 year, 6 months ago

Moderna says updated COVID vaccine is effective against ‘highly-mutated’ BA.2.86 variant

Hindustan Times  

Moderna on Wednesday said clinical trial data showed its updated COVID-19 vaccine will likely be effective against the highly-mutated BA.2.86 subvariant of the coronavirus that has raised fears of a resurgence of infections. The Omicron offshoot carries more than 35 mutations in key portions of the virus compared with XBB.1.5, the dominant variant through most of 2023 and the target …

Highly mutated Covid variant detected in four countries: What experts said
1 year, 6 months ago

Highly mutated Covid variant detected in four countries: What experts said

Hindustan Times  

A new, highly mutated, lineage of the Covid-19 virus – BA.2.86 has been detected by public health authorities in some countries, sparking concerns of a renewed surge in infections. While, at present, there is no evidence if this version spreads faster or causes more serious illness than its previous ones, the US Centers for Disease Control and Prevention urged people …

A new regime: On the Emergency Use Authorisation regime in India and clinical trials
1 year, 8 months ago

A new regime: On the Emergency Use Authorisation regime in India and clinical trials

The Hindu  

Last week, the Drug Controller General of India cleared, under the provisions of ‘emergency use authorisation’, a new mRNA vaccine for COVID-19 developed by Pune-based Gennova Biopharmaceuticals, a pioneer in India in developing mRNA vaccines. More than evidence-based assessment, it was a technicality in India’s ‘New Drugs and Clinical Trials Rules, 2019’ that allowed EUA in India for COVID-19 vaccines. …

World Health Organization calls for NEW Covid booster shots
1 year, 9 months ago

World Health Organization calls for NEW Covid booster shots

Daily Mail  

The World Health Organization has called for new Covid shots to be developed for this winter that targets mutated variants. The World Health Organization has recommended new Covid shots are developed this winter to target mutated variants The recommendation was made by the WHO's Technical Advisory Group on Covid Vaccine Composition. The above graph shows the number of Americans who …

Studies show XBB.1.16 is not clinically more severe
1 year, 11 months ago

Studies show XBB.1.16 is not clinically more severe

Hindustan Times  

The XBB.1.16 sub-variant of the Omicron strain of the SARS-CoV-2 virus that causes Covid does not exhibit higher clinical severity according to preliminary results from laboratory studies being conducted in the country to know disease characteristics, according to people familiar with the matter. According to the World Health Organisation, mutations at position 478 of the SARS-CoV-2 spike protein have been …

Old Covid Vaccines May Have Low Efficacy; India Should Update Covid Boosters, Dr Randeep Guleria Warns
1 year, 11 months ago

Old Covid Vaccines May Have Low Efficacy; India Should Update Covid Boosters, Dr Randeep Guleria Warns

News 18  

Similar to flu shots, India may need to update its Covid-19 boosters with the latest strain of the coronavirus, former director of All India Institute of Medical Sciences, Dr Randeep Guleria told News18.com. A renowned pulmonologist, Dr Guleria said the vaccines in India are currently using the Wuhan strain or the strain which was circulating in December 2019. “But now, …

COVID-19: WHO tracking VOI XBB.1.5, six other corona variants under monitoring | DETAILS
1 year, 11 months ago

COVID-19: WHO tracking VOI XBB.1.5, six other corona variants under monitoring | DETAILS

India TV News  

COVID-19: The Centre today told the states and Union territories that currently the World Health Organisation is closely tracking one variant of interest, XBB.1.5 and six other variants are under monitoring BQ.1, BA.2.75, CH.1.1, XBB, XBF and XBB.1.16. During a review meeting on the COVID-19 situation, Union Health Minister Mansukh Mandaviya virtually interacted with the health ministers of the states …

No new Covid variants during recent breakout in China: Lancet study
2 years, 1 month ago

No new Covid variants during recent breakout in China: Lancet study

India Today  

New coronavirus variants did not emerge during the recent outbreak of cases in China, said a study published in the medical journal, The Lancet. Samples of 350 locally acquired infections and 63 imported cases were studied during a five-week period beginning in November 2022 - shortly after China abruptly overturned its strict zero-Covid policy. Further, China also administers inactivated whole …

'Coldspots' discovered in Covid virus, may help antibodies fight future variants: Study
2 years, 1 month ago

'Coldspots' discovered in Covid virus, may help antibodies fight future variants: Study

India TV News  

Scientists have discovered regions on the coronavirus which do not change, or 'coldspots', and that antibodies specific for these coldspots may help fight future coronaviruses, according to a new study. According to the study, sieving through over 10 million coronavirus sequences, two PhD students at the Institute for Research in Biomedicine, Switzerland and affiliated with the Università della Svizzera italiana, …

Centre rolls out first nasal Covid vaccine as booster
2 years, 1 month ago

Centre rolls out first nasal Covid vaccine as booster

Hindustan Times  

India on Thursday rolled out the first nasal vaccine against Covid-19, to be administered as a primary or booster dose for adults, potentially widening the pool of people who may take a third vaccine against the infection, cutting tertiary costs, and easing pressures on supply and storage networks. “Being the world’s first intranasal Covid-19 vaccine, this marks a glorious tribute …

Braving a Viral Storm tells the tale of India’s COVID vaccine journey
2 years, 2 months ago

Braving a Viral Storm tells the tale of India’s COVID vaccine journey

The Hindu  

India’s development and production of its own vaccines against COVID-19 was an important part of dealing with the pandemic, pushed by Prime Minister Narendra Modi’s view that the “entrepreneurial state” of government would bear the front-loaded risks of the effort, cushioning the private sector, according to a new book. The authors of Braving a Viral Storm: India’s Covid-19 Vaccine Story, …

Can Your Vaccine Protect You Against BF.7? India Isolates New Strain, Begins Study to Test Efficacy
2 years, 2 months ago

Can Your Vaccine Protect You Against BF.7? India Isolates New Strain, Begins Study to Test Efficacy

News 18  

A sample of SARS-CoV-2 virus containing the BF.7, a sub-lineage of the Omicron variant, has successfully been isolated by India to assess the efficacy of available vaccines. “Scientists are studying whether the currently available vaccines are effective in preventing infections or serious illness caused by the new sub-variant,” a source was quoted as saying. India has reported at least four …

Fourth Covid vaccine unwarranted right now but increased surveillance needed: experts
2 years, 2 months ago

Fourth Covid vaccine unwarranted right now but increased surveillance needed: experts

Deccan Chronicle  

NEW DELHI: Several countries are administering a third and even fourth Covid booster shot but India, where many fully vaccinated individuals have not taken even one, is not there yet, say experts while stressing on the need for a structured and systematic response. If that infection did not trigger enough Omicron-specific immunity none of the vaccines currently available in India …

Staying prepared: On scaling up the pace of COVID-19 genome sequencing
2 years, 2 months ago

Staying prepared: On scaling up the pace of COVID-19 genome sequencing

The Hindu  

Three years after strict enforcement of its Zero-COVID strategy, China abandoned it abruptly, leading to a jump in cases each day — an estimated 250 million people were infected in 20 days in December, according to the media, overwhelming hospitals and crematoria. Though this variant was found in many countries, including India, months ago, there is fear that the uncontrolled …

Understanding Omicron BF.7, The New Covid-19 Variant From China, And How India Should Prepare
2 years, 2 months ago

Understanding Omicron BF.7, The New Covid-19 Variant From China, And How India Should Prepare

ABP News  

The Covid-19 pandemic is dragging on too long, and there is still no respite in sight. Coronaviruses And Variants The original virus that first emerged from Wuhan in China is termed SARS CoV-2 and is a strain of the coronavirus that causes Covid-19. The original virus and viral mutations and variants are routinely monitored through sequence-based surveillance, laboratory studies, and …

Holistic data analysis, upgraded vaccines to determine India's future battle with Covid: Epidemiologist Dileep Mavlankar
2 years, 2 months ago

Holistic data analysis, upgraded vaccines to determine India's future battle with Covid: Epidemiologist Dileep Mavlankar

India Today  

India has raised surveillance in light of the surge in Covid cases in many countries, particularly China, from new variants of the virus. Dileep Mavlankar, senior epidemiologist and director of the Indian Institute of Public Health, Gandhinagar, says it will be difficult to develop sufficiently effective medication and vaccines against Covid till the time scientists have a handle on how …

OPINION | Covid threat: India is on a stronger wicket compared to China, says Dr Guleria
2 years, 2 months ago

OPINION | Covid threat: India is on a stronger wicket compared to China, says Dr Guleria

India TV News  

As scary visuals come in from China of bodies of Covid-19 victims being laid out inside containers, the Centre and state governments have revved up arrangements to ensure full preparedness in the face of fresh challenge. In my prime time show Aaj Ki Baat on Friday night, we showed fresh videos and pictures of large number of Covid patients undergoing …

Scared by Possibility of Fourth Covid Wave? Fret Not, Situation in India Not as Severe as China
2 years, 2 months ago

Scared by Possibility of Fourth Covid Wave? Fret Not, Situation in India Not as Severe as China

News 18  

As Covid-19 cases are spreading rapidly through China again and in some other parts of the world, India is stepping up its virus combating measures especially as the BF.7 variant, behind the new surge, has been detected in the country. By October 21, 2021, India had administered a total of 1 billion Covid-19 vaccine doses to its population, and by …

BF.7 variant of COVID-19 not worrisome for India, assures senior scientist Rakesh Mishra
2 years, 2 months ago

BF.7 variant of COVID-19 not worrisome for India, assures senior scientist Rakesh Mishra

The Hindu  

Allaying fears about BF.7 variant of coronavirus, a prominent scientist on December 23 said it is a sub-variant of Omicron strain and that India need not worry too much about its severity on the population. The former director of CSIR-Centre for Cellular and Molecular Biology further said China has been witnessing an unprecedented surge in COVID-19 cases as the neighbouring …

A concerning sequence: The Hindu Editorial on a new coronavirus strain and a spurt in cases in China
2 years, 2 months ago

A concerning sequence: The Hindu Editorial on a new coronavirus strain and a spurt in cases in China

The Hindu  

The spurt in coronavirus cases reported out of China has triggered global alarm. India’s Health Ministry has issued a directive to States to send positive samples to the Indian SARS-CoV-2 Genomics Consortium to check for new, concerning strains. There is scarce monitoring and mask mandates for public gatherings, airports and railway stations have been removed everywhere; so, low numbers do …

New Year, Old Fear: China's Covid Surge Shows Why India Can Breathe Sigh of Relief For Now
2 years, 2 months ago

New Year, Old Fear: China's Covid Surge Shows Why India Can Breathe Sigh of Relief For Now

News 18  

It was a long haul away from Zero Covid for China. “Population immunity is much higher in India and our research suggests that most people have already been infected with Omicron, with a large fraction having had both Delta and Omicron infections,” said Agrawal. Additional immunity provided by India’s large vaccination programme reduces the potential for major impact, he said, …

Vaccines four times weaker against BQ.1.1 Covid variant
2 years, 3 months ago

Vaccines four times weaker against BQ.1.1 Covid variant

Daily Mail  

A rising Covid subvariant soon to become dominant across the US is significantly more resistant to the updated bivalent vaccines, according to a study. Researchers found that the bivalent Covid booster was effective against the BA.5 variant but only had a fourth of the effective antibodies against the growing BQ.1.1 strain. It is expected to soon take over as the …

COVID-19 vaccines offer significant protection against reinfection: Study
2 years, 3 months ago

COVID-19 vaccines offer significant protection against reinfection: Study

India TV News  

COVID-19 vaccine: A recent study revealed that people earlier infected with the SARS-CoV-2 virus still benefit from vaccination against COVID-19, gaining 60% to 94% protection against reinfection. “In our study, we find a significant vaccine effectiveness against SARS-CoV-2 reinfection, and this shows the importance of vaccination also for those who might be protected by natural immunity," said Katrine Finderup Nielsen …

US renews push for COVID boosters as data show they protect
2 years, 3 months ago

US renews push for COVID boosters as data show they protect

Associated Press  

Americans who got the updated COVID-19 booster shots are better protected against symptomatic infection than those who haven’t — at least for now, U.S. health officials said Tuesday. Speaking at a White House briefing expected to be his last before he retires from the government at the end of year, Fauci said what “may be the final message I give …

'Viruses can really surprise us': Dr Ashish K Jha on whether Covid-19 can become more lethal
2 years, 4 months ago

'Viruses can really surprise us': Dr Ashish K Jha on whether Covid-19 can become more lethal

Hindustan Times  

"There is a widely-held belief that viruses always evolve to become less lethal over time. I don't think that's true," said Dr Ashish K Jha, White House Covid-19 Response Coordinator on Day 1 of the HT Leadership Summit 2022 in conversation with R. Sukumar, Editor-in-Chief, Hindustan Times. Dr Ashish K Jha, White House Covid-19 Response Coordinator According to WHO, over …

'Worst of pandemic should be behind us...': says US Covid expert to HT
2 years, 4 months ago

'Worst of pandemic should be behind us...': says US Covid expert to HT

Hindustan Times  

The world has not seen the last of Covid-19 but the worst days of the pandemic are 'absolutely behind us', Dr Ashish K Jha, the United States government's Covid-19 response co-ordinator, said on Day 1 of the 20th edition of the Hindustan Times Leadership Summit. READ | UK says new Omicron variants could fuel fresh Covid infections Dr Jha said …

CORBEVAX offers better immunity as a heterologous booster shot
2 years, 4 months ago

CORBEVAX offers better immunity as a heterologous booster shot

Deccan Chronicle  

HYDERABAD: Heterologous booster shots have gained significance in light of the waning effect of vaccine doses, especially against different variants of the Covid-19 virus. There is an increase in the immune response to the administration of heterologous booster shots on two counts – first cellular immunity and second, neutralizing antibodies. Administering the CORBEVAX vaccine as a heterologous booster dose provides …

How the COVID-19 pandemic altered the vaccine story in India
2 years, 5 months ago

How the COVID-19 pandemic altered the vaccine story in India

The Hindu  

Last week, Twitter temporarily blocked a post by Florida’s surgeon general Joseph A. Ladapo. Such DNA vaccines, older in provenance than mRNA vaccines, involve inserting DNA for an antigen — or the part of the virus that stimulates the immune system — into a special kind of circular DNA called plasmids that are usually only found in bacteria. In the …

New COVID variant XBB and XBB.1 can evade vaccine antibodies, to be dominant variant in UK, seen in India too
2 years, 5 months ago

New COVID variant XBB and XBB.1 can evade vaccine antibodies, to be dominant variant in UK, seen in India too

India Today  

As experts continue to warn that Covid is not over and China is moving into lockdown-like restrictions once again, the US, UK and even Singapore are witnessing a sharp increase in cases, genomic experts have flagged one of the latest recombinant variants of Covid19, i.e. More antibody evasive Recent research from Yunlong Richard Cao, assistant professor at BIOPIC, Peking University, …

Pfizer says bivalent booster increases antibodies for Omicron variants
2 years, 5 months ago

Pfizer says bivalent booster increases antibodies for Omicron variants

LA Times  

Pfizer Inc. and its German vaccine partner BioNTech said their new COVID-19 booster designed to target the dominant Omicron subvariant produced more antibodies against the intended strains than did the original version of the shot. Pfizer and BioNTech plan to release additional data on the COVID-19 shots in the coming weeks to measure immune responses one month after administration of …

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences
2 years, 5 months ago

Will Two ‘Made-in-India’ Vaccines Be the New Covid Boosters? News18 Decodes Differences

News 18  

India will soon roll out mRNA shots and intranasal vaccines, which will be available on CoWIN, and can be used as boosters against Covid-19. India’s first mRNA shot is only the third mRNA vaccine to be approved for Covid-19 in the world after Pfizer and Moderna. But mortality will be reduced.” Sharing a study of the intranasal vaccines under clinical …

India and China clear needle-free COVID-19 vaccines
2 years, 6 months ago

India and China clear needle-free COVID-19 vaccines

The Independent  

For free real time breaking news alerts sent straight to your inbox sign up to our breaking news emails Sign up to our free breaking news emails Sign up to our free breaking news emails SIGN UP I would like to be emailed about offers, events and updates from The Independent. CanSino Biologics announced Sunday that Chinese regulators have approved …

India's First Nasal Vaccine for Covid-19, Made by Bharat Biotech, Cleared for Emergency Use
2 years, 6 months ago

India's First Nasal Vaccine for Covid-19, Made by Bharat Biotech, Cleared for Emergency Use

News 18  

Bharat Biotech has been given an emergency use authorisation by India’s drug regulator, the Drug Controller General of India, for its intranasal Covid-19 vaccine, Union Health Minister Dr Mansukh Mandaviya tweeted on Tuesday. Big Boost to India's Fight Against COVID-19!Bharat Biotech's ChAd36-SARS-CoV-S COVID-19 recombinant nasal vaccine approved by @CDSCO_INDIA_INF for primary immunization against COVID-19 in 18+ age group for restricted …

New vaccines approved, booster campaign to start in September
2 years, 6 months ago

New vaccines approved, booster campaign to start in September

Dutch News  

The new Pfizer and Moderna booster vaccines have been given approval by the European Medicines Agency for over-12s, and another booster campaign is planned for the second half of September. Although the current vaccines protect against serious sickness, they have become less good at protecting against a coronavirus infection due to mutations in the virus, reports NOS. The EMA expects …

New vaccines approved, booster campaign to start in September
2 years, 6 months ago

New vaccines approved, booster campaign to start in September

Dutch News  

The new Pfizer and Moderna booster vaccines have been given approval by the European Medicines Agency for over-12s, and another booster campaign is planned for the second half of September. Although the current vaccines protect against serious sickness, they have become less good at protecting against a coronavirus infection due to mutations in the virus, reports NOS. The EMA expects …

EU regulator clears tweaked versions of COVID vaccines
2 years, 6 months ago

EU regulator clears tweaked versions of COVID vaccines

Associated Press  

LONDON — The European Medicines Agency has recommended the authorization of two coronavirus vaccines made by Pfizer-BioNTech and Moderna Inc., tweaked to include protection against an early version of the omicron variant. In a statement on Thursday, the EU drug regulator said the two messenger RNA boosters offered protection both against the original version of COVID-19 and the omicron subvariant …

EMA approves updated Pfizer, Moderna Covid vaccines to fight Omicron variant
2 years, 6 months ago

EMA approves updated Pfizer, Moderna Covid vaccines to fight Omicron variant

NL Times  

The European Medicines Agency gave a positive recommendation to authorize the modified versions of the Covid-19 vaccines from Pfizer/BioNTech and Moderna, which should provide better protect against the Omicron variant of the virus, the European Union's medicines watchdog said on Thursday. The committee judged that the modified vaccines provide a strong immune response against both the original variant, and the …

U.S. authorizes updated COVID-19 boosters targeting newest variants
2 years, 6 months ago

U.S. authorizes updated COVID-19 boosters targeting newest variants

LA Times  

The U.S. on Wednesday authorized its first update to COVID-19 vaccines, booster doses that target today’s most common Omicron strains. “Give a clear, forward-looking set of expectations.” Here’s the rub: The original vaccines still offer strong protection against severe disease and death from COVID-19 for most generally healthy people, especially if they got that important first booster dose. First, FDA …

Moderna sues Pfizer and BioNTech over Covid-19 vaccine
2 years, 6 months ago

Moderna sues Pfizer and BioNTech over Covid-19 vaccine

The Independent  

Get the free Morning Headlines email for news from our reporters across the world Sign up to our free Morning Headlines email Sign up to our free Morning Headlines email SIGN UP I would like to be emailed about offers, events and updates from The Independent. Read our privacy policy Moderna is suing US pharmaceutical giant Pfizer and its German …

Moderna sues Pfizer, BioNTech for 'copying technology' in making Covid vaccine
2 years, 6 months ago

Moderna sues Pfizer, BioNTech for 'copying technology' in making Covid vaccine

India TV News  

Moderna sues Pfizer, BioNTech for 'copying technology' in making Covid vaccine Moderna and Pfizer’s two-shot vaccines both use mRNA technology to help patients fight the coronavirus. COVID-19 vaccine maker Moderna is suing Pfizer and the German drugmaker BioNTech, accusing its main competitors of copying Moderna’s technology in order to make their own vaccine. Moderna said Friday that Pfizer and BioNTech’s …

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically
2 years, 6 months ago

An End to Foreign-return Vaccine Woes: India to Offer Remaining Covid-19 Shots Domestically

News 18  

Individuals who have received Covid-19 vaccines abroad and wish to get their second dose or booster shot in India can now do so. The development comes following an August 18 report by the Times of India which highlighted the issues people who had been jabbed abroad faced when they tried to receive a second or third shot here because the …

Pfizer seeks OK of updated COVID vaccine booster for fall
2 years, 6 months ago

Pfizer seeks OK of updated COVID vaccine booster for fall

Associated Press  

Pfizer asked U.S. regulators Monday to authorize its combination COVID-19 vaccine that adds protection against the newest omicron relatives — a key step toward opening a fall booster campaign. Pfizer and its partner BioNTech aim to offer updated boosters to people 12 and older, and shots could begin within weeks if the FDA quickly clears the modified vaccine — a …

Discover Related